Literature DB >> 33019893

Contraceptive Knowledge among Females and Males Receiving Medication Treatment for Opioid Use Disorder Compared to Those Seeking Primary Care.

Heidi S Melbostad1,2, Gary J Badger1, Catalina N Rey1,3, Lauren K MacAfee4, Anne K Dougherty4, Stacey C Sigmon1,2,3, Sarah H Heil1,2,3.   

Abstract

BACKGROUND: Rates of unintended pregnancy among women receiving medication treatment for opioid use disorder (mOUD) are high, likely due in part to low rates of contraceptive use. Lack of knowledge about contraception may be contributing to inadequate contraceptive use.
Objectives: To compare contraceptive knowledge among women and men receiving mOUD relative to a comparison group seeking primary care.
Methods: We surveyed 332 reproductive-age women and men receiving mOUD or primary care with the recently validated 25-item Contraceptive Knowledge Assessment. We examined overall differences between patient groups and between females and males using two-way analyses of variance; individual item differences were tested using logistic regression.
Results: The mean percent of total correct responses was lower among individuals receiving mOUD (n = 167) relative to the comparison group (n = 165), 47.7% vs. 53.8%, respectively (p < .001), and higher among females (n = 169) relative to males (n = 163), 56.1% vs. 45.2%, respectively (p < .001). Individual item analyses revealed patient group and sex differences primarily in the areas of contraceptive efficacy, attributes of contraceptive methods, and fertility awareness.
Conclusion: While there were modest differences between patient groups and sexes, the results suggest a deficit in contraceptive knowledge across all groups. Substance use disorder treatment clinics could be an opportunistic setting in which to provide accurate information about contraception to patients with OUD and other substance use disorders.

Entities:  

Keywords:  Opioid use disorder; contraception; contraceptive knowledge; family planning; medication treatment; reproductive health; substance use treatment; unintended pregnancy

Mesh:

Substances:

Year:  2020        PMID: 33019893      PMCID: PMC7712494          DOI: 10.1080/10826084.2020.1823418

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  29 in total

1.  Reasons for unprotected intercourse: analysis of the PRAMS survey.

Authors:  Mary D Nettleman; Hwan Chung; Jennifer Brewer; Adejoke Ayoola; Philip L Reed
Journal:  Contraception       Date:  2007-03-12       Impact factor: 3.375

2.  Predictors of long-acting reversible contraception use among unmarried young adults.

Authors:  Angela R Dempsey; Caroline C Billingsley; Ashlyn H Savage; Jeffrey E Korte
Journal:  Am J Obstet Gynecol       Date:  2012-02-28       Impact factor: 8.661

3.  Integrating Reproductive and Sexual Health Education and Services Into Opioid Use Disorder Treatment Programs: A Qualitative Study.

Authors:  Stacey L Klaman; Kea Turner; Jennifer Lorvick; Hendrée E Jones
Journal:  J Addict Med       Date:  2020 Sep/Oct       Impact factor: 3.702

4.  Men's perceptions of their roles and responsibilities regarding sex, contraception and childrearing.

Authors:  W R Grady; K Tanfer; J O Billy; J Lincoln-Hanson
Journal:  Fam Plann Perspect       Date:  1996 Sep-Oct

5.  Substance Use Treatment Patient and Provider Perspectives on Accessing Sexual and Reproductive Health Services: Barriers, Facilitators, and the Need for Integration of Care.

Authors:  Lauren K MacAfee; Roxanne F Harfmann; Lindsay M Cannon; Leah Minadeo; Giselle Kolenic; Yasamin Kusunoki; Vanessa K Dalton
Journal:  Subst Use Misuse       Date:  2019-08-27       Impact factor: 2.164

6.  Sperm content of pre-ejaculatory fluid.

Authors:  Stephen R Killick; Christine Leary; James Trussell; Katherine A Guthrie
Journal:  Hum Fertil (Camb)       Date:  2010-12-15       Impact factor: 2.767

7.  Knowledge of contraceptive effectiveness.

Authors:  David L Eisenberg; Gina M Secura; Tessa E Madden; Jenifer E Allsworth; Qiuhong Zhao; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2012-04-06       Impact factor: 8.661

8.  Menstrual cycle length during methadone maintenance.

Authors:  John Schmittner; Jennifer R Schroeder; David H Epstein; Kenzie L Preston
Journal:  Addiction       Date:  2005-06       Impact factor: 6.526

9.  Contraceptive use and pregnancy outcomes among opioid drug-using women: a retrospective cohort study.

Authors:  Charles S Cornford; Helen J Close; Roz Bray; Deborah Beere; James M Mason
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

10.  Contraceptive method use in the United States: trends and characteristics between 2008, 2012 and 2014.

Authors:  Megan L Kavanaugh; Jenna Jerman
Journal:  Contraception       Date:  2017-10-13       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.